Literature DB >> 35058596

Outcomes based on treatment setting in refractory acute myeloid leukemia and other high-grade myeloid malignancies.

Noam E Kopmar1, Megan Othus2, Kelda M Gardner3, Carole Shaw4, Anna B Halpern3,4, Bart L Scott4,5, Paul C Hendrie3,4, Roland B Walter3,4,6,7, Pamela S Becker3,4, Elihu H Estey3,4, Mary-Elizabeth M Percival8,9.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35058596     DOI: 10.1038/s41375-022-01509-0

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  1 in total

Review 1.  New drug approvals in acute myeloid leukemia: an unprecedented paradigm shift.

Authors:  Noam E Kopmar; Elihu H Estey
Journal:  Clin Adv Hematol Oncol       Date:  2019-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.